These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19128)

  • 21. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.
    Krebs-Thomson K; Paulus MP; Geyer MA
    Neuropsychopharmacology; 1998 May; 18(5):339-51. PubMed ID: 9536447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance develops to LSD while the drug is exerting its maximal behavioral effects: implications for the neural bases of tolerance.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1983 Dec; 96(3-4):317-20. PubMed ID: 6676109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains.
    Ouagazzal A; Grottick AJ; Moreau J; Higgins GA
    Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs that antagonize limb flick behavior induced by D-lysergic acid diethylamide (LSD) in cats.
    Haigler HJ; Spring DD
    Psychopharmacology (Berl); 1979 Jun; 64(1):31-4. PubMed ID: 113828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilocarpine, a non-hallucinogenic cholinergic agonist, elicits limb flicking in cats.
    Marini JL
    Pharmacol Biochem Behav; 1981 Dec; 15(6):865-9. PubMed ID: 7323111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert⁺/⁻) mice.
    Kyzar EJ; Stewart AM; Kalueff AV
    Behav Brain Res; 2016 Jan; 296():47-52. PubMed ID: 26340513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The identification of LSD-like hallucinogens using the chronic spinal dog.
    Martin WR; Vaupel DB; Nozaki M; Bright LD
    Drug Alcohol Depend; 1978 Mar; 3(2):113-23. PubMed ID: 272982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-lasting behavioral effects of bromocriptine in cats.
    Gonzalez-Lima F; Stiehl WL; Medina R
    Eur J Pharmacol; 1984 Jul; 102(2):279-87. PubMed ID: 6479221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.
    Appel JB; White FJ; Holohean AM
    Neurosci Biobehav Rev; 1982; 6(4):529-36. PubMed ID: 7177512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
    Fairchild MD; Jenden DJ; Mickey MR; Yale C
    Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electrographic and behavioral effects of various hallucinogens in the free cat].
    Rougeul A; Verdeaux J; Letalle A
    Rev Neurol (Paris); 1969 Jun; 120(6):391-4. PubMed ID: 5379317
    [No Abstract]   [Full Text] [Related]  

  • 32. The stimulus properties of LSD in C57BL/6 mice.
    Winter JC; Kieres AK; Zimmerman MD; Reissig CJ; Eckler JR; Ullrich T; Rice KC; Rabin RA; Richards JB
    Pharmacol Biochem Behav; 2005 Aug; 81(4):830-7. PubMed ID: 16005500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of behavioral and endocrine effects of LSD on zebrafish.
    Grossman L; Utterback E; Stewart A; Gaikwad S; Chung KM; Suciu C; Wong K; Elegante M; Elkhayat S; Tan J; Gilder T; Wu N; Dileo J; Cachat J; Kalueff AV
    Behav Brain Res; 2010 Dec; 214(2):277-84. PubMed ID: 20561961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens.
    Mittman SM; Geyer MA
    Psychopharmacology (Berl); 1989; 98(3):321-9. PubMed ID: 2501811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
    Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anorexia and hyperphagia produced by five pharmacologic classes of hallucinogens.
    Vaupel DB; Morton EC
    Pharmacol Biochem Behav; 1982 Sep; 17(3):539-45. PubMed ID: 6292959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects of serotonergic and dopaminergic drugs in cats following chronic amphetamine administration.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1984 Apr; 99(4):313-24. PubMed ID: 6734730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A characteristic effect of hallucinogens on investigatory responding in rats.
    Geyer MA; Light RK; Rose GJ; Petersen LR; Horwitt DD; Adams LM; Hawkins RL
    Psychopharmacology (Berl); 1979 Sep; 65(1):35-40. PubMed ID: 116288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational determination of dose-response curves in hallucinogen-treated monkeys.
    Brewster JM; Siegel RK; Johnson CA; Jarvik ME
    Int Pharmacopsychiatry; 1976; 11(2):102-8. PubMed ID: 820666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
    Cameron OG; Appel JB
    Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.